Cancer is a disease of genomic instability, a multistep process involving numerous mutations and chromosomal aberrations. Telomeres are highly specialized structures at the ends of chromosomes and function to stabilize and protect the ends of linear chromosomes, therefore determining cellular immortalization. Homeostasis of telomere length is a multifactor-dependent process. Since cellular immortalization is an early and essential step towards cancer, the aim of the present study was to determine immortalization genes that are significant in colon cancer and assess their usefulness in the early diagnosis of this tumor. Expression profiles of 119 transcripts known to be involved in cellular immortalization were assessed with oligonucleotide microarrays in 13 probes of colon adenocarcinoma (low and high clinical stages) and 9 probes of controls (normal colon tissue) and were compared among these groups with the use of the Significant Analysis Microarray (SAM) software and independently verified with the effect size parameter. Eighteen genes with significantly differential expression between high clinical stage colon cancer and the control group, and 21 with differential expression between low clinical stage colon cancer and the control group were identified. Nine genes showing altered expression in both low and high clinical stage colon cancer: ACD (TPP1), DKC1 and ERCC1, MYC, MAX, NBN, NOLA2, PRKDC and HSP82 should, in particular, be the subjects of further studies including QRT-PCR methods.
Introduction
Cancer is a disease of genomic instability, a multistep process involving numerous mutations and/or chromosomal aberrations (1) . Chromosome instability (CIN), resulting in losses or gains of whole chromosomes or their fragments, has been observed in the majority of cancers, at the carcinoma in situ stage of carcinogenesis or even earlier (2) (3) (4) . One of the neoplasms known to be CIN-based is colon cancer (5) .
Most genetic aberrations, characteristic of cancers, including aneuploidy, gene amplification, loss of heterozygosity and gene loss, can be initiated by telomere dysfunction (5, 6) . On the other hand, stability of the telomere length determines cellular immortalization, an early and esential step towards cancer (7) .
Telomeres are made of tandem 5'-TTAGGG-3' repeats and a number of associated proteins responsible for their length and structure. By forming a loop structure, the very end of a telomere is protected from a DNA break, thus preventing chromosomes from end-to-end fusions, misrepair and degradation (6) . This structure, called telosome (shelterin), is associated with six major proteins: TRF1, TRF2, RAP1, TIN2, POT1 and TPP1, and interacts with other proteins and DNA repair factors.
In immortal cells, loss of telomeric DNA due to degradation or incomplete replication is balanced by telomere elongation by DNA polymerase called telomerase (8) , which is composed of the telomerase RNA (hTR) and the catalytic subunit, telomerase reverse transcriptase (hTERT) (9, 10) . It is believed that telomerase is stringently repressed in normal human somatic tissues, but is reactivated in approximately 85-90% of human cancer tissues (11, 12) . Reported data indicate the strong correlation between telomerase expression, telomere length maintenance and carcinogenesis (13, 14) . Approximately 70% of immortalized human cell lines and 85-95% of human cancers exhibit a high expression level of hTERT (15) . Yet, hTERT or telomerase appears to be insufficiently sensitive to be specific markers of carcinogenesis, particularly in telomerase-negative tumors where alternative lengthening of telomeres (ALT) occurs (16, 17) . Indeed, telomere length homeostasis is complex and involves hTR and hTERT gene amplification, regulation of their transcription (directly by transcription factors and indirectly by hormones and growth factors), epigenetic modulation, alternative splicing of hTERT, other posttranscriptional modulations of main telomerase subunits and components, regulation of telomerase complex activity, translocation of the telomerase complex, interaction of cell cycle regulators and telosome proteins (10,18-21). Table I. Factors involved in hTERT and hTR expression, main telomerase subunits.  -----------------------------------------------------------------------------------------------------Gene symbol  Factor name  Reference  Role in transcription  Function in promoter region  ---------------------------------------------------------------------------------------------------- As cellular immortalization plays an important role in chromosome instability and carcinogenesis, knowledge of the mechanisms of telomere dysfunction seems crucial to understand neoplasm formation and to discover early clinical markers of cancer. The aim of the present study was to identify genes whose expression is significant in colon cancer among 70 candidate genes known to be involved in telomere homeostasis. Fig. 1 shows schematically the complex regulation of telomere stability indicating distribution, role and function of the genes analyzed in our study.
Materials and methods
Thirteen homogenates of G1-G2 colon adenocarcinoma tissue, and 9 of normal colon mucosa were obtained from patients >50 years of age and were histopathologically verified. Colon cancer samples were staged according to the 0-IV clinical staging scale.
Microarray methods were applied with the use of HG_U133A microchips (Affymetrix) according to the manufacturer's protocol. Normalization of microarray results was performed with the use of MicroArray Suite 5.0, R with Bioconductor modules and RMAExpress software.
The studied transcriptomes were clustered using hierarchical agglomeration (Ward's method). As shown in Fig. 1 , three clusters of genetic similarity were identified. This allocation was largely compatible with histopathological diagnosis, and the dissected groups of transcriptomes were classified as high stage colon cancer (CH; stages II-IV), low stage colon cancer (CL; stage I and two controls), and normal colon mucosa (N; remaining controls). One stage III colon cancer transcriptom that was clustered with low stage colon cancers was classified as an outlier and excluded from further analysis.
Expression profiles of 119 transcripts (within HG_U133A microchip transcripts), known to be involved in cell immortalization processes (70 genes), were compared among the identified groups with use of the Significant Analysis Microarray (SAM) software. The 'score' and q-value parameters were estimated and verified with ES (effect size) and p-value parameters, independently.
The analyzed transcripts included factors involved in hTERT and hTR expression (Table I) , growth factors engaged in telomerase expression and regulation of its activity (Table II) , the telomerase complex elements and modulators (Table III) , the telosome proteins (Table IV) , and proteins associated with telomeres that are involved in DNA repair pathways (Table V) . Table II . Growth factors involved in telomerase expression and regulation of its activity. - Table III . Telomerase complex factors and modulators. 
Phosphorylation factors of telomerase complex
Results
Eighteen genes with significantly differential expression between high clinical stage colon cancer and the control group, and 21 with differential expression between low clinical stage colon cancer and controls were identified among 119 transcripts involved in immortalization processes. Table VI shows the results of the comparative analysis among the groups, with significance criteria: SAM q-value <5%, SAM score >1.5, ES >1.0 and p<0.05 (22,23). Factor  Reference  Interactions with other  Proposed mechanism  Telomere  symbol  name  telosome proteins  of action  dysfunction  when 
nucleus -----------------------------------------------------------------------------------------------------
a According to ref. 34 with modifications.
-----------------------------------------------------------------------------------------------------

Discussion
Contribution of telomeres to genomic instability and their role in cellular immortalization processes are possible mechanisms leading to carcinogenesis. Telomere shortening or their dysfunction may result in cancer. On the other hand, telomere length maintenance is regarded as a necessary element of oncogenesis (6, 7) . The analysis of the expression profile of genes involved in telomere homeostasis may help understand this paradox and discover new tools for the diagnosis and therapy of colon cancer, a model of carcinogenesis in this study.
In the present study, we demonstrated (in a semiquantitative screening method of oligonucleotide microarrays) that some of the examined transcripts involved in immortalization processes are indicative of colon cancer and are therefore candidates for markers of high or low stage colon cancer. Although the results warrant confirmation in larger study groups, they provide important knowledge of the general trends in expression profiles of immortalization factors. Our broad investigation of cellular immortalization, not only limited to main telomerase subunits but extended to other known telomere homeostasis factors, resulted in valuable findings. Figs. 2 and 3 show schematically genes whose expression was significant under the analyzed clinical conditions.
Telomerase activity and the hTERT expression level have been considered sensitive markers of cancer (yet are not specific to the type of neoplasm) (11,12,24,25) . Notably, in our study, hTERT expression was not a significant discriminator between the studied groups, although it has to be mentioned that the second main telomerase subunit, hTR, was not present on the microchip. Instead various other factors composing the telomerase complex appeared important in colon cancer; such as Dyscerin (DKC1), which was a strongly significant positive differentiator for both CL and CH groups vs. the control. Cohen et al (26) found that DKC1 was one of three (beside telomerase reverse transcriptase and telomerase RNA) critical components of the telomerase complex. In light of this finding, DKC1 appears to be among the most important candidates warranting further investigation. Mutations in DKC1 have been found in the rare disease, dyskeratosis congenita (27) , which is also related to telomerase and telomere homeostasis dysfunction (28) .
Another component of the hTR complex is NOLA2, a member of the same group of proteins as DKC1 and snoRNPs (10) . Its expression was found to be significant in high stage colon cancer. It may therefore be useful in the assessment of disease progression. Other factors significant in the CH group were also found, such as the Hsp90 (HSP82) protein in the hTERT complex. However, strict involvement of DKC1 and NOLAs in telomerase activation (10) makes them potential markers with greater specificity.
An additional important factor, specific to telomere length maintenance, is the telosome component TPP1 (ACD1) which was a positive significant gene in both colon cancer groups in our study. TPP1 is considered a key mediator between main telosome components TRF1, TRF2 and POT1 (19, 29) , and also, by interaction with TIN2, it stabilizes a high level conformation of telosome (30) . Its increased expression Table V . Proteins associated with telomeres that are involved in DNA repair pathways. Gene symbol Factor name  Reference  DNA damage  Interaction with  Telomere dysfunction  function  telosome  when 
-----------------------------------------------------------------------------------------------------
in cancer may reflect telomere disturbances resulting from chromosomal instability and makes it an attractive candidate marker of carcinogenesis.
Notable results have been obtained with some pleiotropic factors, such as cofactors c-Myc/Max, which are transcription factors of hTERT and hTR (31, 32) . Myc was a positive significant gene in the studied colon cancer groups. It has been postulated that c-Myc acts as a transcription factor of many genes, but its contribution to oncogenesis is most likely through telomerase promoter activation (31, 33) . Some authors have shown a correlation between hTERT and c-Myc overexpression in prostate (34) and cervical cancer (35) . In our study, not only c-Myc overexpresssion did not correlate with higher hTERT expression level, but Max protein appeared a strong negative significant factor in both CH and CL groups. Is it simply a negative feedback, or rather a hallmark of more sophisticated mechanisms of Myc/Max complex regulation? It has also been suggested that the transforming activities of Myc extend beyond its ability to activate hTERT gene expression and hence telomerase activity (32) . However, such strong associations with colon cancer indicate importance of these transcription factors for further investigation. The other pleiotropic factors contributing to immortalization in our study were significant DNA repair family proteins ERCC1, PRKDC, RAD51L3, RAD54L and NBN. All of them interact with stable proteins of telosome. Particularly, nibrin (NBS1, NBN) warrants further analyses, due to its influence on alternate lengthening of telomeres 
Score' indicates a rate of significance, positive values indicate overexpression of transcripts, and negative values, silencing of transcription. Groups of factors: CC, cell cycle factors; CS, catalytic hTERT subunit of telomerase; GF, growth factors; PH, phosphorylation factors; RS, RNA subunit of telomerase; T, telosome; TF, transcription factors. (ALT) (36) . ALT is independent of telomerase activation, and it is noted in approximately 10% of neoplasms (16, 17) . The most popular hypothesis of the mechanism of ALT is homologous recombination between ends of chromosomes (37), which NBS1 is postulated to take part in. In the context of our results, NBS1 appears a significant factor with the potential for discerning cases of cancer that are based on ALT mechanisms of immortalization.
Division of the study group according to transcriptive similarity, albeit highly compatible with clinical division, imposed inclusion of two control cases in the low stage colon cancer group, which can be considered a limitation of this study. However, as these two transcriptomes came from samples of normal colon mucosa of patients with colon cancer (Fig. 1) , we assumed that these two transcriptomes featured a transcriptive profile of early oncogenesis prior to morphological manifestation.
The mechanisms that induce and influence genomic instability and immortalization processes in cancer, in general and more specifically in colon cancer, are only partly understood. Although our data are preliminary, we believe that the knowledge gained from our study may aid in the diagnosis of cancer and the development of therapeutic tools, as well as provide a novel insight into cell immortalization processes. Figure 3 . Transcripts differing significantly between the high stage colon cancer and control groups according to 'score' parameter (SAM analysis) for a q-value <0.05. Intensity of grey indicates the degree of significance. Shape of figures: oval, telomerase/telomere lengthening activator; rectangle, telomerase/telomere lengthening inhibitor; other shapes, multiple actions; dashed outline, factor not present on microchip.
